Validation of a novel point of care testing device for sickle cell disease

BACKGROUND: Sickle cell disease is one of the most common inherited blood disorders. Universal screening and early intervention have significantly helped to reduce childhood mortality in high-resource countries. However, persons living in low-resource settings are often not diagnosed until late chil...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanter, Julie, Telen, Marilyn J., Hoppe, Carolyn, Roberts, Christopher L., Kim, Jason S., Yang, Xiaoxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573998/
https://www.ncbi.nlm.nih.gov/pubmed/26377572
http://dx.doi.org/10.1186/s12916-015-0473-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573998/
https://www.ncbi.nlm.nih.gov/pubmed/26377572
http://dx.doi.org/10.1186/s12916-015-0473-6

Ejemplares similares